Program

Thursday 6th May 2010

0825 – Welcome Robert Grimer

0830 - Session 1 – Getting the Diagnosis Right

Chairs: David Spooner and Kirsten Sundby Hall

1.1

1.2

1.3


 

1.4

1.5

1.6
 
 

1.7

1.8

 

1.9

1.10 

1.11

1.12

08:30       ARE WE GETTING BETTER AT DIAGNOSING SARCOMAS? - View presentation

G Smith, Royal Orthopaedic Hospital, Birmingham, UK

08:35      THE SYMPTOM INTERVAL IN CHILDREN AND ADOLESCENTS WITH SOFT TISSUE SARCOMAS

P.Daolio, Istituto Ortopedico G.Pini Milan, Italy

08:40      SARCOMA CENTRE DELAYS THREE TIMES AS LONG AS PATIENT’S DELAYS IN RETROPERITONEAL SARCOMAS - View presentation

JM Seinen, Skåne University Hospital in Lund, Sweden

08:45       PROTON MAGNETIC RESONANCE SPECTROSCOPIC EVALUATION OF CHOLINE: TUMOUR

               MARKER OF SOFT TISSUE SARCOMA?

Madhabananda Kar, Bhubaneswar, India.

09:00       WHAT DO ‘WORRYING’ BONES TURN OUT TO BE? - View presentation

A Malhas, Royal Orthopaedic Hospital, Birmingham UK 

09:05      IS DELAYED DIAGNOSIS RELATED TO EPIPHYSEAL INVASION AND/OR  OUTCOME IN PAEDIATRIC METAPHYSEAL OSTEOSARCOMA? A MULTICENTRIC STUDY - View presentation

B. Vázquez, University of Navarra, Spain

09:10      MULTIPLE OSTEOCHONDROMAS AND MALIGNANT TRANSFORMATION: CLINICAL, RADIOLOGICAL AND PATHOLOGICAL FEATURES - View presentation

EJA Dootjes, Leiden University Medical Centre, The Netherlands

09:15       THE DIAGNOSIS OF PRIMARY LONG BONE TUMORS BY EXPERT SYSTEMS.

NV Kochergina, Blokhin Oncology Research Center, Moscow, Russia

09:30       CHANGING CLINICAL PRESENTATION OF ANGIOSARCOMAS AFTER BREAST CANCER:FROM LATE TUMORS IN EDEMATOUS ARMS TO EARLIER TUMORS ON THE THORACIC WALL

E Styring, Lund University Hospital, Sweden.

09:35     TUMOURS OF THE HAND. A RETROSPECTIVE ANALYSIS OF 142 CASES. - View presentation

F Machacek, Gersthof Orthopaedic Hospital, Austria

09:40      DIAGNOSTIC VALUE OF WHOLE BODY PET-SCAN AND BONE SCAN FOR  STAGING

PATIENTS WITH EWING’S SARCOMA – EXPERIENCE IN 175 PATIENTS FROM A TERTIARY 

CARE CANCER CENTRE

S Gulia, Tata Memorial Hospital, Mumbai, India.

09:45     WIKIPEDIA AND OSTEOSARCOMA: AN EDUCATIONAL OPPORTUNITY AND PROFESSIONAL RESPONSIBILITY FOR EMSOS - View presentation

A Leithner, Medical University of Graz, Graz, Austria

1000 - Coffee break + Poster Viewing

1040 - Session 2 – Benign and Metastases

Chairs: Roger Tillman and Antonie Taminiau

2.1 

 

2.2 
 

2.3

2.4 

2.5

2.6


 

2.7 


 

2.8

10:40      ABC CAN EASILY BE TREATED WITH POLYDOCANOL - View presentation
 

                 O Brosjö, Karolinska University Hospital, Stockholm, Sweden
 

10:45       RESULTS OF RADIO-FREQUENCY ABLATION OF SPINAL OSTEOID OSTEOMAS IN CLOSE PROXIMITY TO NEUROLOGICAL STRUCTURES.

JJ Gregory, Oswestry, Shropshire, UK.

10:50         EFFICACY OF ZOLEDRONIC ACID IN THE TREATMENT OF BENIGN OSTEOLYTIC BONE LESIONS - View presentation
 

SK Garg, Government Medical College & Hospital, Chandigarh, India.
 

10:55         PHOTOCHEMICAL INTERNALIZATION (PCI) AS AN ADJUNCT TO INTRALESIONAL SURGERY IN A HUMAN SARCOMA MODEL

O-J Norum, The Norwegian Radium Hospital, Montebello, Oslo, Norway
 

11:10         MUSCLE SPECIFIC MICRORNAS CAN DISTINGUISH RHABDOMYOSARCOMA FROM OTHER PEDIATRIC TUMORS.

M Miyachi, Kyoto Prefectural University of Medicine, Kyoto, Japan

11:15         SELECTIVE EMBOLIZATION OF BONE METASTASES WITH N-2-BUTYL

                 CYANOACRYLATE: 309 PROCEDURES IN 7 YEARS

P.Ruggieri, University of Bologna, Istituto Ortopedico Rizzoli, Bologna, Italy
 

11:20        PROGNOSTIC FACTORS FOR SURVIVAL AFTER SURGERY OF METASTATIC

                 SPINAL CORD COMPRESSION - View presentation

PDS Dijkstra, Leiden University Medical Center, Leiden, The Hague, The Netherlands
 

11:25        THE ECONOMIC BURDEN OF MANAGING METASTATIC BONE TUMOURS

                 ON THE PROVISION OF TRAUMA SERVICES - View presentation

A Gulati, Leicester Royal Infirmary, UK

1145 - EMSOS Lecture – Chair Roger Tillman

  Prof Rob Coleman - Bone Targeted Therapy in Malignancy

1230 - 1330 LUNCH

1330 – Invited lecture – Chair Robert Grimer

Prof Mark Gebhardt – The role of bone allografts in 2010

1400 - Session 3 – Chondrosarcoma and new techniques

Chairs: Bass Hassan and Pietro Ruggieri

 3.1



 

3.2

 

3.3

3.4


 

3.5
 

3.6

 

3.7


 

3.8




 

3.9

3.10

14:00        GALECTIN-1 IS A POWERFUL MARKER TO DISTINGUISH CHONDROBLASTIC OSTEOSARCOMA AND CONVENTIONAL CHONDROSARCOMA - View presentation

A Gomez-Brouchet, Rangueil Hospital, Toulouse, France
 

14:05        CHARACTERIZATION OF RARE CHONDROSARCOMA SUBTYPES

JVMG Bovée, Leiden University Medical Center, Leiden, The Netherlands

14:10        BCL2 INHIBITION SENSITIZES CHONDROSARCOMA TO CONVENTIONAL CHEMOTHERAPY IN VITRO

JG van Oosterwijk, Department of Pathology, Leiden, The Netherlands
 

14:15        CHONDROSARCOMA OF THE CHEST WALL: PRIMARY DIAGNOSTICS IS DECISIVE FOR OUTCOME

HCF Bauer, B Widhe Karolinska Hospital, Stockholm, SWEDEN

14:20        6,5 -YEARS CLINICAL FOLLOW-UP OF NINETY PATIENTS WITH LOW-GRADE CENTRAL CHONDROSARCOMA OF LONG BONES, TREATED WITH INTRALESIONAL CURETTAGE FOLLOWED BY PHENOL, ETHANOL AND BONE GRAFTING

SHM Verdegaal, Leiden University Medical Center, Leiden, The Netherlands
 

14:35        CRYOSURGERY FOR LOW GRADE INTRAMEDULLARY CHONDROSARCOMA

Y Gortzak, Tel-Aviv "Sourasky" Medical Center, Tel-Aviv, Israel.

14:40        CURETTAGE AND CEMENTATION OF LOW GRADE CHONDROSARCOMAS

Murat Hýz,,Departments of Orthopaedics and Traumatology and Pathology Cerrahpaþa Faculty of Medicine, Ýstanbul, Turkey
 

14:45        EN-BLOC RESECTION, EXTRACORPOREAL IRRADIATION, AND RE-IMPLANTATION IN LIMB SALVAGE FOR BONY MALIGNANCIES.  RESULTS FROM THE FIRST 50 CASES AT A MEAN OF 8.5 YEARS.

WJS Aston, Royal Prince Alfred Hospital, Sydney,
 

14:50        DIAPHYSEAL RECONSTRUCTION WITH EXTRACORPOREAL IRRADIATED AUTOGENOUS TUMOR BONE - View presentation

A Gulia, Tata Memorial Hospital, Mumbai, India.
 

14:55        EXTRACORPOREAL IRRADIATION AND REIMPLANTATION OF BONE  -  WHAT WORKS AND WHAT DOESN’T! - View presentation

S Mottard, Royal Orthopaedic Hospital, Birmingham, UK

1510 - Afternoon Tea

1530

        Poster Discussion 1 – Chairs – Yehuda Kollender and team

1600 - Session 4 – Pelvis and Humerus – what works?

 4.1



 

4.2

4.3

4.4

4.5

4.6

4.7 

4.8

 16:00        PROXIMAL HUMERUS RECONSTRUCTION AFTER TUMOUR RESECTION: COMPARING BOTH OSTEOARTICULAR ALLOGRAFT, ENDOPROSTHESIS AND BOTH COMBINED - View presentation

Michiel AJ van de Sande, Leiden University Medical Centre, The Netherlands

16:05        FUNCTIONAL OUTCOME OF PROXIMAL HUMERAL RECONSTRUCTION FOLLOWING TUMOUR RESECTION. ENDOPROSTHESIS VERSUS SHOULDER ARTHRODESIS USING VASCULARIZED AUTOGRAFT - View presentation

WA Ebeid, Orthopaedic Department, Cairo University, Cairo, Egypt.
 

16:10        REPLACEMENT OF THE PROXIMAL HUMERUS WITH MUTARS TUMOR ENDOPROSTHESES

B Lehner, University of Heidelberg, Heidelberg, Germany
 

16:15        PROXIMAL HUMERUS RECONSTRUCTION IN BONE TUMOR SURGERY: OSTEOARTICULAR ALLOGRAFTS VS ALLOGRAFT-PROSTHESIS COMPOSITES

DA Campanacci, Azienda Ospedaliera Universitaria Careggi, Florence, Italy
 

16:30        EWING SARCOMA OF THE BONY PELVIS: A COMPARISON BETWEEN TUMOURS LOCALIZED TO THE SACRUM AND THE HIP BONES. THE SCANDINAVIAN SARCOMA GROUP EXPERIENCE - View presentation

Asle Hesla, Karolinska Hospital, Stockholm, Sweden

16:35        PELVIC EWING'S SARCOMA: OUR EXPERIENCE AND EVALUATION OF PROGNOSTIC FACTORS - View presentation

A Dramis, Royal Orthopaedic Hospital, Birmingham, UK
 

16:40        LONG-TERM CLINICAL RESULTS OF SADDLE PROSTHESIS AFTER RESECTION OF PERIACETABULAR TUMORS - View presentation

J.A. Jansen, Leiden University Medical Center, Leiden, The Netherlands.
 

16:45        OUTCOMES OF PRIMARY BONE TUMOURS OF THE PELVIS - THE ROH EXPERIENCE

L Jeys, Royal Orthopaedic Hospital, Birmingham, UK

1700 - End

1830 - Depart for gala dinner

Friday 7^th May 2010

0830 – EMSOS Business meeting

0900 - Session 5 – Osteosarcoma  - improving outcomes

 Chairs: Stefan Bielack and Judith Bovee

5.1
 

5.2 

5.3 

5.4
 

5.5

5.6

5.7

5.8

09:00    OUR EXPERIENCE OF NEOADJUVANT TREATMENT IN METASTATIC OSTEOSARCOMA AT PRESENTATION - View presentation

              G. Machak, N.N. Blokhin Cancer Center, Moscow, Russian Federation

 09:05     LONG-TERM RESULTS OF NON-SURGICAL TREATMENT OF STAGE IIB OSTEOSARCOMA OF THE   EXTREMITIES - View presentation

Machak G, N.N. Blokhin Cancer Center, Moscow, Russian Federation

 09:10     LONG—TERM RESULTS IN CHILDREN BONE SARCOMA PATIENTS TREATED BY DISTAL   FEMUR MEGAPROSTHESES - View presentation

Marco Manfrini, IV Clinica Ortopedica a indirizzo Oncologico, Istituto Ortopedico Rizzoli, Bologna, Italy

 09:15     AGE-SPECIFIC RECRUITMENT VARIATIONS IN A LARGE INTERGROUP OSTEOSARCOMA STUDY, EURAMOS-1 (NCT00134030)

Stefan Bielackz, Olgahospital, Stuttgart

 09:30     OSTEOSARCOMA WITH POOR NECROSIS AND CLOSE MARGINS - AMPUTATION OR LIMB SALVAGE? - View presentation

Simon Carter, Royal Orthopaedic Hospital, Birmingham, UK

 09:35     PRIMARY BONE TUMOURS - HOW CLOSE IS ACCEPTABLE?

              Lee Jeys, Royal Orthopaedic Hospital, Birmingham, UK

 09:40     LONG TERM RESULTS OF AN ELECTROMAGNETIC NON-INVASIVE EXPANDABLE PROSTHESE, AFTER RESECTION OF THE KNEE IN 27 CHILDREN

E Mascard, Hospital Saint Vincent de Paul, Paris, France

 09:45     ENHANCEMENT OF RADIATION RESPONSE IN OSTEOSARCOMA AND      RHABOMYOSARCOMA CELL LINES BY HISTONE DEACETYLASE INHIBITION - View presentation

C Blattmann, University Children´s Hospital of Heidelberg, Germany

1000 - Coffee break + poster viewing

1040 - Session 6 – Surgical options – what works and what doesn’t?

         Chairs: Simon Carter and Domenico Campanacci

6.1 


 

6.2


 

6.3


 

6.4 

 

6.5 

6.6

6.7
 

6.8

10:40     SURGICAL TREATMENT OF BONE TUMOURS OF THE PROXIMAL FIBULA

Dieckmann, Department of Orthopaedics and Tumour Orthopaedics,University of Münster, Germany
 

10:45     WHAT TREATMENT IN SARCOMAS OF THE FOOT: CONSERVATION OR AMPUTATION? ABOUT 54 TUMOURS OF THE FRENCH SARCOMA GROUP GSF-GETO.

E Mascard, Hospital Saint Vincent de Paul, Paris, France

10:50     EWING’S SARCOMA LOCAL RECURRENCE - PREDICTABLE OR PREVENTABLE? - View presentation

CR Chandrasekar, Royal Orthopaedic Hospital, Birmingham, UK

10:55     EXTRA-ARTICULAR RESECTION OF BONE TUMOURS

Lee Jeys, Royal Orthopaedic Hospital, Birmingham, UK

11:10     KNEE ARTHRODESIS WITH A MODULAR PROSTHESIS SYSTEM: RESULTS AND COMPLICATIONS IN PRIMARY AND REVISION IMPLANTS

P Ruggieri, University of Bologna, Istituto Ortopedico Rizzoli, Bologna, Italy

11:15     COMPARATIVE STUDY BETWEEN ENDOPROSTHETIC REPLACEMENT AND HIP

              ARTHRODESIS USING A VASCULARIZED FIBULAR GRAFT IN THE MANAGEMENT OF  MALIGNANT TUMOURS OF THE PROXIMAL FEMUR - View presentation

H Wafa, Cairo University, Egypt

11:20     EFFECTIVENESS OF INTRAVENOUS BISPHOSPHONATE IN TREATMENT OF LOCAL RECURRENCES GIANT CELL TUMORS. - View presentation

S Dadia, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel

11:25     OSSEOINTEGRATION IN TRANSFEMORAL AMPUTEES: THE GOTHENBURG EXPERIENCE.

Ö Berlin, Department of Orthopaedics, Sahlgren University Hospital, Gothenburg, Sweden

1145 - Campanacci Lecture

  Prof J Y Blay  - Improving collaboration across Europe for sarcoma research and care

1230 - 1330  LUNCH

1330

Poster Discussion 2 – Chairs – Otte Brosjo and team

1400 - Session 7 – The longer term results

Chairs: Ramses Forsyth and Bruce Morland

7.1
 

7.2

7.3

7.4

7.5

7.6

7.7
 

7.8

7.9

 

7.10 

7.11

7.12

14:00     A SIMPLE PROGNOSTIC SCORING SYSTEM FOR NON METASTATIC OSTEOSARCOMA OF THE EXTREMITY - View presentation

S. Ferrari, Istituto Ortopedico Rizzoli, Bologna Italy  

14:05     RISK BASED FOLLOW-UP PROTOCOL FOR PATIENTS WITH OSTEOSARCOMA

               Long J, Royal Orthopaedic Hospital, Birmingham, UK

14:10     PRE-OPERATIVE SERUM C-REACTIVE PROTEIN IS AN INDEPENDENT PROGNOSTIC FACTOR FOR SURVIVAL IN PATIENTS WITH OSTEOSARCOMA

              PT Funovics, Vienna General Hospital, Vienna, Austria

14:15     SARCOMA DEVELOPMENT AFTER CURETTAGE AND BONE GRAFTS OF BENIGN BONE LESIONS

              P Picci, Laboratory of Experimental Oncology, Istituto Ortopedico Rizzoli, Bologna, Italy

14:30     TARGETING SSX IN SARCOMA

              Barry Wolahan, Karolinska Institutet, Stockholm, Sweden.

14:35     SYNOVIAL SARCOMAS USUALLY METASTASIZE AFTER MORE THAN FIVE YEARS: A MULTICENTER, RETROSPECTIVE ANALYSIS WITH MINIMUM FOLLOW-UP OF 10 YEARS FOR SURVIVORS

               AH Krieg, Children’s University and University Hospital Basel, Inselspital Bern

14:40     REDUCTION OF BONE MINERAL DENSITY AFTER CHEMOTHERAPY FOR BONE SARCOMAS

              U Pirker-Frühauf, Medical University Graz, Graz, Austria

14:45     EVALUATION OF QUALITY OF LIFE IN PATIENTS TREATED WITH RESECTION AND RECONSTRUCTION OF THE UPPER OR LOWER LIMB FOR BONE SARCOMAS

              P Ruggieri, University of Bologna, Istituto Ortopedico Rizzoli, Bologna, Italy

15:00     PROGNOSTIC FACTORS FOR LOCAL RECURRENCE AND SURVIVAL IN PATIENTS WITH SOFT TISSUE SARCOMAS: A CONSECUTIVE SERIES OF 2445 PATIENTS TREATED FOR STS

              Lee Jeys, Royal Orthopaedic Hospital, Birmingham, UK

15:05     EXTRASKELETAL OSTEOSARCOMA: CLINICO-PATHOLOGIC FEATURES AND RESULTS OF MULTIMODAL MANAGEMENT - View presentation

               N. Fabbri, Istituto Ortopedico Rizzoli, Bologna, Italy

15:10     LATE COMPLICATIONS AFTER EXCISION OF SOFT TISSUE SARCOMA OF EXTREMITIES WITH OR WITHOUT RADIOTHERAPY: THE EXPERIENCE OF DEPARTMENT OF ORTHOPEDIC ONCOLOGY IN FLORENCE

               G. Beltrami, Human Pathology and   Radiotherapy, AOUC, CTO, Florence, Italy

15:15     INFECTIONS IN ORTHOPEDIC ONCOLOGY: INCIDENCE, TREATMENT AND OUTCOME.

              P Ruggieri, University of Bologna, Istituto Ortopedico Rizzoli, Bologna, Italy

1530 - EMSOS 2011 – Ramses Forsyth

1540 -  Prizes and awards

1600 - Vale